A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics

Clinical trial NCT00886821 · COMPLETED

Trial details

NCT number: NCT00886821
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2008-10-01
Primary completion: 2011-06-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.